Charles Schwab Investment Management Inc Vertex Pharmaceuticals Inc Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,626,347 shares of VRTX stock, worth $664 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
1,626,347
Previous 1,605,986
1.27%
Holding current value
$664 Million
Previous $753 Million
0.48%
% of portfolio
0.15%
Previous 0.15%
Shares
29 transactions
Others Institutions Holding VRTX
# of Institutions
1,724Shares Held
221MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$10.9 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$9.45 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.7 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.82 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$3.67 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $105B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...